Skip to main content
NIH funding notice PA-18-815

Better Defining Growth Medium to Improve Reproducibility of Cell Culture (SBIR) (R43/R44 - Clinical Trial Not Allowed)

Closed on April 5, 2021.

Posted
June 5, 2018
Close date
April 5, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,805,569 in first-year total cost, median $224,843.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IMST-H (15)]4
  2. Special Emphasis Panel[ZRG1 IMST-F (15)]2

Most frequent institutions

  1. ARTERIOCYTE, INC.1
  2. CERES NANOSCIENCES, LLLP1
  3. DEFINED BIOSCIENCE, INC.1
  4. ENABLE LIFE SCIENCES LLC1
  5. POTOMAC AFFINITY PROTEINS, LLC1
Competing awards under PA-18-815 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021HiDef B8: Commercialization and scaled production of defined, robust, and cost-effective media for iPSCs1R44GM140750-01A1BURRIDGE, PAUL W.MUOTRI, ALYSSON R.REES, STEVEN DDEFINED BIOSCIENCE, INC., CA$760,359ZRG1
2021Selection system for identifying protein-specific folding tags that enable purification of native cytokines from E. coli1R43GM140633-01A1BRYAN, PHILIP NPOTOMAC AFFINITY PROTEINS, LLC, MD$224,806ZRG1
2020Improving the clarification, characterization, and homogeneity of animal serum through Nanotrap nanoparticle technology1R43GM135943-01LEPENE, BENJAMIN SCOTTCERES NANOSCIENCES, LLLP, VA$224,879ZRG1
2020A Novel Serum Alternative for Ex-vivo Expansion of Natural Killer Cells for Immunotherapy1R43GM137742-01OHRI, RACHITENABLE LIFE SCIENCES LLC, MA$224,000ZRG1
2019Scalable manufacturing of human platelet lysate for next generation cell-based technologies1R43GM133224-01SAMBERG, MEGHANARTERIOCYTE, INC., MA$224,994ZRG1
2019Generation of serum- free media for expansion of human T lymphocytes and CD34+ HSCs using High Dimensional Design of Experiments (HD-DoE)1R43GM133241-01JENSEN, JANTRAILHEAD BIOSYSTEMS, INC., OH$146,531ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.